NEW DELHI–In 2005, with barely US$300 in her bank account, Nidhi Saxena took the bold step forward to pursue her dream of becoming an entrepreneur and founded Karmic Lifesciences. Nidhi Saxena Today, the Mumbai-headquartered clinical research organization (CRO) clocks revenue of about US$10 million and is targeting to increase this number to US$19.3 million by 2014. The company provides a range of services from new drug development to concept clinic services, and counts leading global pharmaceutical and biotech companies among its key customers. It leverages cloud computing and its own IT capabilities to offer cost-efficient products including its Web-based clinical platforms kClinion, kTrials and kMetrics. Saxena, 38, who is also company president and CEO, saw the opportunity in the CRO market which was lacking in innovation and identified three key focus areas: data entry, data compliance, and drug compliance. In an interview with ZDNet Asia, she discusses new projects Karmic is working on and India’s potential to be a leading CRO destination. Q: You’ve worked with companies like GE Capital, WNS North America, Wipro and Hexaware. How did you come up with the idea of Karmic? CROs offered a lot of opportunity for innovation. How did you go about it? In… Read full this story
- Open source database firms look to plug security gap
- Travel firms use IT to beat recession blues
- Telecom growth lifts Indian market
- Asian firms closing gap with Western brands
- Academic programs aim to close diversity gap in medicine
- Cleveland Clinic creating center for AI in healthcare
- 'Safety Net' Clinics Uneven in Delivery of Help to Quit Smoking
- 30 innovations that improved the world in 2017
- Downturn? What downturn? Indian software firms rock on!
- Indian firms turn to software-as-a-service
Indian clinical research firm looks to fill innovation gap have 275 words, post on www.zdnet.com at April 8, 2012. This is cached page on Drudgereport. If you want remove this page, please contact us.